Daniel A Sweeney

Statistics

Publications

Citations

9.7K

H-Index

Active since

2010

Affiliations

National Institute of Allergy and Infectious Diseases(Current)

Daniel A Sweeney is an author at National Institute of Allergy and Infectious Diseases specializing in treatment of coronavirus infections, placebo-controlled efficacy assessment, and treatment.

Publications per year

2010–2024

Publications

Remdesivir for the Treatment of Covid-19 — Final Report

John H. Beigel, Kay M Tomashek, Lori E. Dodd et al. · New England Journal of Medicine · 2020 · 7.7K citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +15

Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19

André C. Kalil, Thomas F. Patterson, Aneesh K. Mehta et al. · New England Journal of Medicine · 2020 · 1.9K citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +14

Anthrax Lethal and Edema Toxins Produce Different Patterns of Cardiovascular and Renal Dysfunction and Synergistically Decrease Survival in Canines

Daniel A Sweeney, Xizhong Cui, Steven B. Solomon et al. · The Journal of Infectious Diseases · 2010 · 53 citations · Full text

Veterinary Medicine, Toxicology, Veterinary Toxicology +14

SARS-CoV-2 RNA and Nucleocapsid Antigen Are Blood Biomarkers Associated With Severe Disease Outcomes That Improve in Response to Remdesivir

Kanal Singh, Kevin Rubenstein, Viviane Callier et al. · The Journal of Infectious Diseases · 2024 · 13 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

1–4 of 4